BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3295155)

  • 1. Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders.
    Ciclitira PJ; Macartney JC; Evan G
    J Pathol; 1987 Apr; 151(4):293-6. PubMed ID: 3295155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High c-myc protein expression in benign colorectal lesions correlates with the degree of dysplasia.
    Pavelic ZP; Pavelic L; Kuvelkar R; Gapany SR
    Anticancer Res; 1992; 12(1):171-5. PubMed ID: 1567165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical study of HLA-DR expression in superficial epithelium and in lamina propria of colonic mucosa in children with Crohn's disease and nonspecific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(2):143-51. PubMed ID: 9814381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new murine monoclonal antibody, CMU10, as a marker for colonic carcinoma and precancerous conditions.
    Yang GY; Shamsuddin AM
    Arch Pathol Lab Med; 1995 May; 119(5):454-7. PubMed ID: 7748075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
    Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
    Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential expression of major histocompatibility antigens in the normal gastrointestinal tract, in chronic inflammatory intestinal diseases and neoplasms].
    Momburg F; Hämmerling GJ; Schürmann G; Betzler M; Schlag P; Möller P
    Z Gastroenterol Verh; 1989 Jul; 24():111-4. PubMed ID: 2474918
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of oncogene products as tumour markers.
    Chan S; Sikora K
    Cancer Surv; 1987; 6(2):185-207. PubMed ID: 3322544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.
    Selby WS; Janossy G; Mason DY; Jewell DP
    Clin Exp Immunol; 1983 Sep; 53(3):614-8. PubMed ID: 6577996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis.
    Noffsinger AE; Miller MA; Cusi MV; Fenoglio-Preiser CM
    Cancer; 1996 Dec; 78(11):2307-12. PubMed ID: 8940999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease.
    Greenstein AJ; Panvelliwalla DK; Katz LB; Heimann TM; Donnelly J; Pertsimlidis D; Geller S; Smith H; Aufses AH
    Am J Gastroenterol; 1982 Apr; 77(4):212-5. PubMed ID: 7072691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and genetic alterations in pre-cancerous cells in the colon.
    Lundy J; Chen J; Wang P; Fromowitz F; Schuss A; Lynch S; Brugge J; Viola MV
    Anticancer Res; 1988; 8(5A):1005-13. PubMed ID: 3052255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosae.
    Bara J; Gautier R; Daher N; Zaghouani H; Decaens C
    Cancer Res; 1986 Aug; 46(8):3983-9. PubMed ID: 3524800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical study of colonic mucosa macrophages in children with Crohn's disease and ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(4):283-91. PubMed ID: 10347713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease.
    Danis VA; Harries AD; Heatley RV
    Clin Exp Immunol; 1984 Apr; 56(1):159-66. PubMed ID: 6713728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation in normal, preneoplastic and neoplastic gastrointestinal cells.
    Deschner EE; Lipkin M
    Clin Gastroenterol; 1976 Sep; 5(3):543-61. PubMed ID: 1022374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.